Why the study?
Direct oral anticoagulants could offer a more convenient alternative to warfarin without frequent monitoring and with fewer drug-drug interactions for managing left ventricular thrombi.
Do direct oral anticoagulants provide a safe and effective alternative to warfarin for the management of left ventricular thrombi?
Do direct oral anticoagulants provide a safe and effective alternative to warfarin for the management of left ventricular thrombi?
DOACs may offer a convenient alternative to warfarin for left ventricular thrombi; dedicated RCTs are still needed to confirm efficacy and safety.
Direct oral anticoagulants can potentially provide a more convenient oral alternative for the management of left ventricular thrombi than Warfarin. These medications do not require frequent monitoring and have less drug-drug interactions. Randomized controlled trials are needed to further demonstrate their efficacy and safety in this setting.
No takes yet. Share an insight, caveat, or question.
Shokr et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: